Complete Clinical Response to Neoadjuvant Chemotherapy in a 54-year-old Male with Askin Tumor

被引:5
|
作者
Mulsow, J. [1 ]
Jeffers, M. [2 ]
McDermott, R. [3 ]
Geraghty, J. [1 ]
Rothwell, J. [1 ]
机构
[1] Adelaide & Meath Hosp, Dept Surg, Dublin 24, Ireland
[2] Adelaide & Meath Hosp, Dept Cellular Pathol, Dublin 24, Ireland
[3] Adelaide & Meath Hosp, Dept Oncol, Dublin 24, Ireland
关键词
Neoadjuvant therapy; chest wall; sarcoma; PRIMITIVE NEUROECTODERMAL TUMOR; EWINGS-SARCOMA;
D O I
10.1055/s-0029-1186198
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Askin tumor is a tumor of the thoracopulmonary region that most commonly affects children and adolescents. These rare tumors are a form of primitive neuroectodermal tumor and typically carry a poor prognosis. Treatment is multimodal and consists of a combination of neoadjuvant chemotherapy, radical resection, and adjuvant chemo- and radiotherapy or all of the above. Surgery is advocated in most cases. We report a case of Askin tumor in a 54-year-old male who showed rapid and complete response to neoadjuvant chemotherapy. This allowed potentially radical surgery to be avoided. At one-year follow-up he remains disease-free.
引用
收藏
页码:306 / 308
页数:3
相关论文
共 50 条
  • [31] Pathological Complete Response After Neoadjuvant Imatinib in a Recurrent Duodenal Gastrointestinal Stromal Tumor (GIST)
    Marques-Antunes, Joana
    Carvalho, Lucia
    Pereira, Silvia
    Ferreira, Tiago
    Nora, Mario
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [32] Survival outcomes after pathologic complete response with neoadjuvant endocrine therapy vs. neoadjuvant chemotherapy: a retrospective national database study
    Tori C. Nierenberg
    Samantha M. Thomas
    Ian Halliday
    Astrid Botty van den Bruele
    Akiko Chiba
    Kendra J. Modell Parrish
    Hannah E. Woriax
    Maggie L. DiNome
    Kelly E. Westbrook
    Jennifer K. Plichta
    Breast Cancer Research and Treatment, 2025, 212 (1) : 161 - 172
  • [33] Tumor Volume Predicts for Pathologic Complete Response in Rectal Cancer Patients Treated With Neoadjuvant Chemoradiation
    Yang, Fan
    Hill, Jordan
    Abraham, Aswin
    Ghosh, Sunita
    Steed, Tanner
    Kurtz, Clay
    Joseph, Kurian
    Yun, Jihyun
    Warkentin, Brad
    Thai, JoAnn
    Nijjar, Tirath
    Severin, Diane
    Tankel, Keith
    Fairchild, Alysa
    Usmani, Nawaid
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (10): : 405 - 409
  • [34] Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
    Kim, Dongjin
    Yu, Yeuni
    Jung, Ki Sun
    Kim, Yun Hak
    Kim, Jae-Joon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 162 - 177
  • [35] Clinical and biochemical predictors of tumor response after neoadjuvant therapy in rectal cancer
    Bedrikovetski, Sergei
    Traeger, Luke
    Vather, Ryash
    Moore, James W.
    Sammour, Tarik
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (03) : 365 - 373
  • [36] Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapy
    Shi, Jing
    Li, Ming
    Yang, Rongzhi
    IMMUNOTHERAPY, 2020, 12 (09) : 641 - 652
  • [37] The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy
    Nuvoli, Susanna
    Galassi, Sarah
    Gelo, Ilaria
    Rocchitta, Gaia
    Fancellu, Alessandro
    Serra, Pier Andrea
    Madeddu, Giuseppe
    Spanu, Angela
    ONCOLOGY REPORTS, 2018, 39 (05) : 2055 - 2062
  • [38] The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response
    Ai, Di
    Arrey, Eliel N.
    Postlewait, Lauren M.
    Gao, Yuan
    Li, Xiaoxian
    HISTOPATHOLOGY, 2025, : 1112 - 1120
  • [39] MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
    Mette S. van Ramshorst
    Claudette E. Loo
    Emilie J. Groen
    Gonneke H. Winter-Warnars
    Jelle Wesseling
    Frederieke van Duijnhoven
    Marie-Jeanne T. Vrancken Peeters
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2017, 164 : 99 - 106
  • [40] Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy
    Caroline Malhaire
    Fatine Selhane
    Marie-Judith Saint-Martin
    Vincent Cockenpot
    Pia Akl
    Enora Laas
    Audrey Bellesoeur
    Catherine Ala Eddine
    Melodie Bereby-Kahane
    Julie Manceau
    Delphine Sebbag-Sfez
    Jean-Yves Pierga
    Fabien Reyal
    Anne Vincent-Salomon
    Herve Brisse
    Frederique Frouin
    European Radiology, 2023, 33 : 8142 - 8154